The epileptogenic effect of seizures induced by hypoxia: The role of NMDA and AMPA/KA antagonists

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 2, 2003, Pages 303-311

  Rubaj, Andrzej ^a   Zgodziński, Witold ^a   Sieklucka Dziuba, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Hypoxia; MK 801; NBQX; Seizures

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR AGONIST; BICUCULLINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; 2,3 DIOXO 6 NITRO 7 SULFAMOYLBENZO(F)QUINOXALINE; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; AMPA RECEPTOR; DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYLASPARTIC ACID; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CLONIC SEIZURE; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; EPILEPTOGENESIS; FEMALE; HYPOXIA; LATENT PERIOD; LEARNING; LOW DRUG DOSE; MICROSCOPE; MOUSE; NONHUMAN; OBSERVATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE INJURY; TONIC SEIZURE; ANIMAL; ANOXIA; AVOIDANCE BEHAVIOR; BRAIN LEVEL; DRUG ANTAGONISM; DRUG EFFECT; EPILEPSY; METABOLISM; PATHOPHYSIOLOGY; SEIZURE;

ANIMALS; ANOXIA; AVOIDANCE LEARNING; BICUCULLINE; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MICE; N-METHYLASPARTATE; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES;

EID: 18744363615     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00998-X     Document Type: Article

References (68)

1. Allen H., Iversen L. Phencyclidine, dizcilopine, and cerebrocortical neurons. Science. 247:1990;221.
2. Andine P., Orwar O., Jacobson I., Sandberg M., Hagberg H. Changes in extracellular amino acids and spontaneous neuronal activity during ischemia and extended reflow in the CA1 of the rat hippocampus. J. Neurochem. 57:1991;222-229.
3. Andine P., Jacobson I., Hagberg H. Enhanced calcium uptake by CA1 pyramidal cell dendrites in the postischemic phase despite subnormal evoked field potentials: excitatory amino acid dependency and relationship to neuronal damage. J. Cereb. Blood Flow Metab. 12:1992;773-783.
4. Applegate C.D., Jensen F., Burchfiel J.L., Lombroso C. The effects of neonatal hypoxia on kindled seizure development and electroconvulsive shock profiles. Epilepsia. 37:1996;723-727.
5. Araki T., Kanai Y., Murakami F., Kato H., Kogure K. Postischemic changes in the binding of excitatory and inhibitory neurotransmitters in the gerbil brain. Pharmacol. Biochem. Behav. 45:1993;945-949.
6. Baker A.J., Zornow M.H., Scheller M.S. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57:1991;1370-1379.
7. Benveniste H., Drejer J., Schousboe A., Diemer N. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
8. Bowdler J.M., Green A.R. Regional rat brain benzodiazepine receptor number and γ-aminobutyric acid concentrations following a convulsion. Br. J. Pharmacol. 76:1982;291-298.
9. Buchan A.M. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? Cerebrovasc. Brain Metab. Rev. 2:1990;1-26.
10. Buchan A., Li H., Pulsinelli W.A. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe, forebrain ischemia. J. Neurosci. 11:1991;1049-1056.
11. Buchan A.M., Li H., Cho S., Pulsinelli W.A. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci. Lett. 132:1991;255-258.
12. Celesia G.G., Grigg M.M., Ross E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch. Neurol. 45:1988;781-784.
13. Dalkara T., Ayata C., Demirci M., Erdemli G., Onur R. Effects of cerebral ischemia on N-methyl-D-aspartate and dihydropyridine-sensitive calcium currents. An electrophysiological study in the rat hippocampus in situ. Stroke. 27:1996;127-133.
14. Dubinsky J.M., Kristal B.S., Elizondo-Fournier M. An obligate role for oxygen in the early stages of glutamate-induced delayed neuronal death. J. Neurosci. 15:1995;7071-7078.
15. Dzhala V., Ben-Ari Y., Khazipov R. Seizures accelerate anoxia-induced neuronal death in the neonatal rat hippocampus. Ann. Neurol. 48:2000;632-640.
16. Emerson M.R., Nelson S.R., Samson F.E., Pazdernik T.L. Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats. Brain Res. 825:1999;189-193.
17. Fleischer J.E., Tateishi A., Drummond J.C. MK-801, an excitatory amino acid antagonist, does not improve neurologic outcome following cardiac arrest in cats. J. Cereb. Blood Flow Metab. 9:1989;795-804.
18. Green A.R., Minchin M.C.W., Vincent N.D. Inhibition of GABA release from slices prepared from several brain regions of rats at various times following a convulsion. Br. J. Pharmacol. 92:1987;13-18.
19. Green A.R., Cross A.J., Snape M.F., De Souza R.J. The immediate consequences of middle cerebral artery occlusion on GABA synthesis in mouse cortex and cerebellum. Neurosci. Lett. 138:1992;141-144.
20. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 174:1957;247-259.
21. Heim C., Bortolotto Z.A., Cavalheiro E.A., Sontag K.H. Transient occlusion of rat carotid arteries decreases susceptibility to pilocarpine seizures. Brain Res. 544:1991;253-259.
22. Hiramatsu M., Cho A.K., Nabeshima T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166(3):1989;359-366.
23. Hori N., Carpenter D.O. Functional and morphological changes induced by transient in vivo ischemia. Exp. Neurol. 129:1994;279-289.
24. 2+ blockade of NMDA receptors. Neurosci. Lett. 173:1994;75-78.
25. Iadarola M.J., Gale K. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol. Cell Biochem. 39:1981;305-329.
26. Ishige K., Chen Q., Sagara Y., Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J. Neurosci. 21(16):2001;6069-6076.
27. Jensen F.E. An animal model of hypoxia-induced perinatal seizures. Ital. J. Neurol. Sci. 16:1995;59-68.
28. Jensen F.E. Acute and chronic effects of seizures in the developing brain: experimental models. Epilepsia. 40(Suppl. 1):1999;51-58. [discussion 64-66].
29. Jensen F.E., Holmes G.L., Lombroso C.T., Blume H.K., Firkusny I.R. Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia. 33:1992;971-980.
30. Jensen F.E., Blume H., Alvarado S., Firkusny I.R., Geary C. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia. 36:1995;966-972.
31. Jobe P.C., Dailey J.W., Wernicke J.F. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit. Rev. Neurobiol. 13(4):1999;317-356.
32. Kanner A.M., Balabanov A. Depression and epilepsy: how closely related are they? Neurology. 58(8 Suppl. 5):2002;S27-S39.
33. Kanter E.D., Kapur A., Haberly L.B. A dendritic GABAA-mediated IPSP regulates facilitation of NMDA-mediated responses to burst stimulation of afferent fibers in piriform cortex. J. Neurosci. 16:1996;307-312.
34. Kawai K., Penix L.P., Kawahara N., Ruetzler C.A., Klatzo I. Development of susceptibility to audiogenic seizures following cardiac arrest cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;248-258.
35. Kilpatrick C.J., Davis S.M., Hopper J.L., Rossiter S.C. Early seizures after acute stroke. Risk of late seizures. Arch. Neurol. 49:1992;509-511.
36. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
37. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-A14.
38. Li H., Buchan A.M. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cereb. Blood Flow Metab. 13:1993;933-939.
39. Loscher W., Honack D. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur. J. Pharmacol. 215(2-3):1992;199-208.
40. Lowe I.P., Robins R., Eyerman G.S. The fluorimetric measurement of glutamic decarboxylase and its distribution in the brain. J. Neurochem. 3:1953;8-18.
41. Marty A., Llano I. Modulation of inhibitory synapses in the mammalian brain. Curr. Opin. Neurobiol. 5:1995;335-341.
42. Nellgard B., Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12:1992;2-11.
43. Nurse S., Corbett D. Neuroprotection after several days of mild, drug-induced hypothermia. J. Cereb. Blood Flow Metab. 16:1996;474-480.
44. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
45. Prehn J.H., Welsch M., Backhauss C., Nuglisch J., Ausmeier F., Karkoutly C.et al. Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia. Brain Res. 630(1-2):1993;10-20.
46. Riveros N., Orrego F. N-methylasparate-activated calcium channels in rat brain cortex slices. Effects of calcium channel blockers and of inhibitory and depressant substances. Neuroscience. 17:1999;541-546.
47. Roach G.W., Kanchuger M., Mangano C.M., Newman M., Nussmeier N., Wolman R.et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N. Engl. J. Med. 335:1996;1857-1863.
48. Rubaj A., Gustaw K., Zgodzinski W., Kleinrok Z., Sieklucka-Dziuba M. The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol. Biochem. Behav. 67:2000;65-70.
49. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl.). 94:1988;491-495.
50. Sheardown M.J., Suzdak P.D., Nordholm L. AMPA but not NMDA receptor antagonism is neuroprotective in gerbil global ischemia, even when delayed 24 hours. Eur. J. Pharmacol. 236:1993;347-353.
51. Siesjo B.K., Bengtsson F., Grampp W., Theander S. Calcium, excitotoxins, and neuronal death in the brain. Ann. N. Y. Acad. Sci. 568:1989;234-251.
52. Snyder B.D., Hauser W.A., Loewenson R.B., Leppik I.E., Ramirez-Lassepas M., Gumnit R.J. Neurologic prognosis after cardiopulmonary arrest: III. Seizure activity. Neurology. 30:1980;1292-1297.
53. So E.L., Annegers J.F., Hauser W.A., O'Brien P.C., Whisnant J.P. Population-based study of seizure disorders after cerebral infarction. Neurology. 46:1996;350-355.
54. Sutton J., Simmonds M.A. Effect of acute and chronic pentobarbitone on the gamma-aminobutyric acid system in rat brain. Biochem. Pharmacol. 23:1974;1801-1808.
55. Thoresen M., Hallstrom A., Whitelaw A., Puka-Sundvall M., Loberg E.M., Satas S.et al. Lactate and pyruvate changes in the cerebral gray and white matter during posthypoxic seizures in newborn pigs. Pediatr. Res. 44:1998;746-754.
56. Towfighi J., Housman C., Mauger D., Vannucci R.C. Effect of seizures on cerebral hypoxic-ischemic lesions in immature rats. Brain Res. Dev. Brain Res. 113:1999;83-95.
57. Uchino H., Smith M.L., Bengzon J., Lundgren J., Siesjo B.K. Characteristics of postischemic seizures in hyperglycemic rats. J. Neurol. Sci. 139:1996;21-27.
58. Vanicky I., Cizkova D., Prosbova T., Marsala M. Audiogenic seizures after neck tourniquet-induced cerebral ischemia in the rat. Brain Res. 766:1997;262-265.
59. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 16(1):1996;373-379.
60. Volpe B.T., Davis H.P., Towle A., Dunlap W.P. Loss of hippocampal CA1 pyramidal neurons correlates with memory impairment in rats with ischemic or neurotoxin lesions. Behav. Neurosci. 106:1992;457-464.
61. Volterra A., Trotti D., Racagni G. Glutamate uptake is inhibited by arachidonic acid and oxygen radical via two distinct additive mechanisms. Mol. Pharmacol. 46:1994;986-992.
62. Wang L., Huang Z. Effect of clonazepam on brain development of mice. Dev. Pharmacol. Ther. 15:1990;21-25.
63. Watanabe K., Ashby C.R. Jr., Katsumori H., Minabe Y. The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur. J. Pharmacol. 398(2):2000;239-246.
64. Wei H., Fiskum G., Rosenthal R.E., Perry D.C. Global cerebral ischemia and reperfusion alters NMDA receptor binding in canine brain. Mol. Chem. Neuropathol. 30:1997;25-39.
65. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett. 142(1):1992;5-8.
66. Wijdicks E.F., Young G.B. Myoclonus status in comatose patients after cardiac arrest. Lancet. 343:1994;1642-1643.
67. Young R.S., During M.J., Aquila W.J., Tendler D., Ley E. Hypoxia increases extracellular concentrations of excitatory and inhibitory neurotransmitters in subsequently induced seizure: in vivo microdialysis study in the rabbit. Exp. Neurol. 117:1992;204-209.
68. Younkin D.P., Delivoria-Papadopoulos M., Maris J., Donlon E., Clancy R., Chance B. Cerebral metabolic effects of neonatal seizures measured with in vivo 31P NMR spectroscopy. Ann. Neurol. 20:1986;513-519.